Novo Nordisk A/SNVONYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank0
3Y CAGR-54.2%
5Y CAGR-29.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-54.2%/yr
vs +50.3%/yr prior
5Y CAGR
-29.6%/yr
Recent deceleration
Acceleration
-104.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 1.72% |
| 2024 | 21.42% |
| 2023 | 52.35% |
| 2022 | 17.89% |
| 2021 | 15.18% |
| 2020 | 9.93% |
| 2019 | 2.88% |
| 2018 | 3.50% |
| 2017 | 2.87% |
| 2016 | 10.55% |